Patent · US Active

Method of treating psoriatic arthritis, psoriasis, and chronic obstructive pulmonary disease with a novel 2,5-substituted pyrimidines

US10391099B2 · kind B2 · utility

0Cited by

4References

1Claims

0Family size

Assignee

Gruenenthal GmbH · DE

Inventors

Antonio Nardi · Gambellara, IT
Florian Jakob · Aachen, DE
Ingo Konetzki · Warthausen, DE
Tobias Craan · Niedernberg, DE
Christian Hesslinger · Zoznegg, DE

Key dates

Filing date	Nov 17, 2016
Grant date	Aug 27, 2019
Priority date	—
Expiry date	Nov 17, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to novel substituted condensed pyrimidine compounds of general formula (I) in which the chemical groupings, substituents and indices are as defined in the description, and to their use as medicaments, in particular as medicaments for the treatment of conditions and diseases that can be treated by inhibition of the PDE4 enzyme.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.